Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by KennyH


COTY

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

  FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On...

July 15, 2022

NOG

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

  FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On...

July 15, 2022

TTNP

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

  FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On...

July 15, 2022

TTNP

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

NOG

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

COTY

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

COTY

FSD Pharma Files Investigational New Drug Application “IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 2, 2022

NOG

FSD Pharma Files Investigational New Drug Application “IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 2, 2022

TTNP

FSD Pharma Files Investigational New Drug Application “IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 2, 2022

TTNP

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   ...

May 11, 2022

NOG

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   ...

May 11, 2022

COTY

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   ...

May 11, 2022

TTNP

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

May 3, 2022

NOG

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

May 1, 2022

COTY

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 30, 2022

TTNP

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John...

April 26, 2022

NOG

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John...

April 24, 2022

COTY

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John...

April 22, 2022

TTNP

FSD Pharma Inc: Lucid MS Video

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 19, 2022

NOG

FSD Pharma Inc: Lucid MS Video

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 17, 2022

1 2 3 4 Next